Alzheimer’s disease may damage the brain in two phases, according to new research published in Nature Neuroscience on Monday.

With the perpetual rise of technology and the proliferation of AI, we are moving faster than ever. New inventions have accelerated nearly every aspect of our lives, including medicine. In 2023, the ...

Alzheimer’s Disease May Damage the Brain in Two Phases - NIH Study Uncovers Which Cell Types May Be Harmed First ...

LVS Advisory discusses an investment they made in Medpace in the third quarter of 2024. Click here to read more about their ...

MELBOURNE, Australia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore will be participating in a fireside ...

Circadian rhythms of macrophages are altered by conditions associated with the tumor microenvironment, including acidic pH. This may be responsible for the heterogeneity in circadian clock gene ...

As we try and tackle this problem, novel and exciting avenues of research are being explored in data science and machine ...

DelveInsight's 'Metastatic Castration-Sensitive Prostate Cancer Pipeline Insight 2024' report provides comprehensive global ...

We are The Associated Press. We have a long-standing role setting the industry standard for ethics in journalism. It is our job — more than ever before — to report the news accurately and honestly.

The Surgical Learning Hub (SLH) and the Global Network for Weapon-Wounded Care aim to reduce morbidity and mortality rates among weapon-wounded patients by improving the quality of hospital and ...

For the first nine months of 2024, The LVS Growth Portfolio gained 27.1% and the LVS Event-Driven Portfolio gained 4.9%, net ...

Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”) a clinical-stage biopharmaceutical company ...